FDA Inspection 1170368 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on May 18, 2022 in St Augustine, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- St Augustine, FL (United States)